Understanding SEC Rule 2a-5 and its requirements for valuations
As of September 2022, Registered Investment Advisers (RIAs) are required to comply with SEC Rule 2a-5, also known as the "Good Faith Determination of Fair Value," which sought to more robustly define the way funds approach asset valuations. The Rule furthers the SEC’s focus on transparency and accuracy of financial reporting. The key shift? It defines responsibilities for fund boards to ensure that valuations are determined in good faith.
So while valuations have always been a critical aspect of managing a portfolio, Rule 2a-5 adds new layers of accountability for Registered Investment Advisers (RIAs), formalizing standards that had previously been considered best practices by some. Furthermore, while Exempt Reporting Advisers (ERAs) are not covered by the Rule, some have begun adopting practices from Rule 2a-5 as part of their approach to valuation oversight.
What’s changed?
Defining board requirements for oversight of fair value determinations
The Rule introduced specific requirements of the board of directors in order to determine the fair value of a fund’s investments. These requirements include: 1) periodically assessing and managing material risks associated with fair value determinations; 2) selecting, applying, and testing fair value methodologies; 3) testing for appropriateness and accuracy; and 4) overseeing and evaluating any pricing services used.
Additionally, Rule 2a-5 allows the board to assign responsibilities for determining fair value to a “valuation designee” (i.e., investment adviser often), subject to additional conditions and oversight requirements. Interestingly, the Rule specifically indicates that the valuation designee is expected to “reasonably segregate” the process of determining fair value from the portfolio management function. This could be read as encouraging funds to responsibly balance input from investors with that of the valuation designee to ensure that valuations are being assessed objectively, reducing the risk of conflicts of interest. By including independent third-party professionals, fund boards can further enhance balanced determination of fair value.
We take a look at each of the new requirements below:
Assessing and managing material risks
The Rule requires that funds assess potential risks that could arise when determining fair value for the fund’s investments, including conflicts of interest or market dislocations.
Applying fair valuation methodologies
The SEC now requires documented valuation methodologies that are to be applied across a fund. This is to make sure all assets are valued transparently and regularly reviewed.
- In order to apply fair value methodologies consistently, the board or valuation designee will have to specify the key inputs and assumptions used in generating fair value to each portfolio holding.
- Boards or valuation designees must periodically review valuation methodologies for appropriateness and accuracy, making changes where necessary.
Aumni provides a hub for valuation-related data such as company capitalization and key performance indicators (KPIs), allowing you to easily update and maintain records. We also provide insight into historical trends.
Requirement for regular testing
Fund boards or valuation designees are required to regularly test valuation approaches to ensure they remain suitable as market dynamics shift. The SEC requires ongoing validation; though did not specify a minimum frequency of testing.
Monitoring third-party pricing services
If third-party pricing services are used, boards are responsible for overseeing the process for approving, monitoring, and evaluating the pricing service provider. For example, Aumni’s independent valuation partner, PricingDirect, is considered a third-party pricing service whose use could be specified in a fund’s valuation policy.
Preparing for compliance
To support compliance efforts, it’s helpful to establish a formal process for board oversight. This might include collaborating with boards to set up regular review meetings where valuation methods can be examined, approved, and documented.
Many of our customers have developed standardized valuation processes across portfolios, ensuring they reflect current market conditions. Periodic reviews may be scheduled to test and, if necessary, adjust these methods in response to evolving market trends.
Additionally, regular testing of valuation methods can help meet the Rule 2a-5 requirements. Setting up a testing schedule that incorporates scenario analyses and stress testing will ensure that valuation methodologies continue to perform effectively and stay aligned with market dynamics.
Explore how Aumni’s platform can help streamline your audit process and keep you aligned with regulatory requirements.
Get a demo
©2023 JPMorgan Chase & Co. All rights reserved. JPMorgan Chase Bank, N.A. Member FDIC.
This material is not the product of J.P. Morgan’s Research Department. It is not a research report and is not intended as such. This material is provided for informational purposes only and is subject to change without notice. It is not intended as research, a recommendation, advice, offer or solicitation to buy or sell any financial product or service, or to be used in any way for evaluating the merits of participating in any transaction. Please consult your own advisors regarding legal, tax, accounting or any other aspects including suitability implications, for your particular circumstances or transactions. J.P. Morgan and its third-party suppliers disclaim any responsibility or liability whatsoever for the quality, fitness for a particular purpose, non-infringement, accuracy, currency or completeness of the information herein, and for any reliance on, or use of this material in any way. Any information or analysis in this material purporting to convey, summarize, or otherwise rely on data may be based on a sample or normalized set thereof. This material is provided on a confidential basis and may not be reproduced, redistributed or transmitted, in whole or in part, without the prior written consent of J.P. Morgan. Any unauthorized use is strictly prohibited. Any product names, company names and logos mentioned or included herein are trademarks or registered trademarks of their respective owners.
Aumni, Inc. (“Aumni”) is a wholly-owned subsidiary of JPMorgan Chase & Co. Access to the Aumni platform is subject to execution of an applicable platform agreement and order form and access will be granted by J.P. Morgan in its sole discretion. J.P. Morgan is the global brand name for JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide. Aumni does not provide any accounting, regulatory, tax, insurance, investment, or legal advice. The recipient of any information provided by Aumni must make an independent assessment of any legal, credit, tax, insurance, regulatory and accounting issues with its own professional advisors in the context of its particular circumstances. Aumni is neither a broker-dealer nor a member of any exchanges or self-regulatory organizations.
383 Madison Ave, New York, NY 10017